A comparitive study of intravitreal aflibercept 1.0mg versus 2.0 mg in management of central diabetic macular edema
Not Applicable
- Conditions
- Health Condition 1: H358- Other specified retinal disorders
- Registration Number
- CTRI/2020/12/030058
- Lead Sponsor
- Command Hospital Chandimandir
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 age more then 18 years both male and female
2 centre involving diabetic macular edema
Exclusion Criteria
1 media opacity precluding OCT measurements at inception
2 prior laser photocoagulation
3 prior antivegf administartion or intravitreal steroids
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method